Bladder cancer genomic landscape study aims to spawn new biomarker-guided therapies
NEW YORK – In a collaborative effort supported by the Bladder Cancer Advocacy Network (BCAN), researchers from cancer centers across the United States have explored the genomic landscape of bladder cancer to potentially inform new treatment strategies guided by biomarkers. The results of the project, titled Urothelial Cancer – Genomic Analysis to Improve Patient Outcomes …
Bladder cancer genomic landscape study aims to spawn new biomarker-guided therapies Read More »